Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

OUTLAST: First Multiple-Dose Efficacy Study of the IXT-m200 antibody in Patients with METH Use Disorder


Collapse Overview 
Collapse sponsor award id
U01DA055481


Collapse Biography 
Collapse contributor

Collapse Time 
Collapse start date
2021-10-01

Collapse end date
2024-07-31